Pharmacotherpy and Alzheimer’s Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach

E-ISSN： 1873-4286|22|16|2411-2430

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.16, 2016-05, pp. : 2411-2430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of memantine for the treatment of Alzheimer’s disease

By Ferris Steven H

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2305-2313

Informa Healthcare

Access to resources Recommend Favorite

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?

By Doggrell Sheila

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1857-1860

Informa Healthcare

Access to resources Recommend Favorite

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite

Clinically tested drugs for Alzheimer’s disease

By McGeer Edith G McGeer Patrick L

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1143-1151

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory drugs: a hope for Alzheimer’s disease?

By Hüll M. Lieb K. Fiebich B.L.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 671-683

Informa Healthcare

Access to resources Recommend Favorite